These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 15056039

  • 1. Cold-adapted, live attenuated influenza vaccine.
    Glezen WP.
    Expert Rev Vaccines; 2004 Apr; 3(2):131-9. PubMed ID: 15056039
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group.
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [Abstract] [Full Text] [Related]

  • 3. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD, CAIV-T Study Group.
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [Abstract] [Full Text] [Related]

  • 4. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
    Belshe RB, Gruber WC.
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec 29; 356(1416):1947-51. PubMed ID: 11779396
    [Abstract] [Full Text] [Related]

  • 5. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.
    Bergen R, Black S, Shinefield H, Lewis E, Ray P, Hansen J, Walker R, Hessel C, Cordova J, Mendelman PM.
    Pediatr Infect Dis J; 2004 Feb 29; 23(2):138-44. PubMed ID: 14872180
    [Abstract] [Full Text] [Related]

  • 6. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years.
    Belshe RB, Nichol KL, Black SB, Shinefield H, Cordova J, Walker R, Hessel C, Cho I, Mendelman PM.
    Clin Infect Dis; 2004 Oct 01; 39(7):920-7. PubMed ID: 15472840
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP.
    Pediatr Infect Dis J; 2008 Oct 01; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003 Oct 01; 4(5):312-9. PubMed ID: 12952502
    [Abstract] [Full Text] [Related]

  • 12. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.
    Pediatrics; 2007 Sep 01; 120(3):e553-64. PubMed ID: 17698577
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
    Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J.
    Vaccine; 2009 Feb 11; 27(7):1101-10. PubMed ID: 19095024
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H, Farhat CK, Tregnaghi MW, Madhi SA, Razmpour A, Palladino G, Small MG, Gruber WC, Forrest BD, D153-P504 LAIV Study Group.
    Pediatr Infect Dis J; 2009 May 11; 28(5):365-71. PubMed ID: 19395948
    [Abstract] [Full Text] [Related]

  • 15. New developments in influenza vaccine technology: a potential new prevention strategy for employers and managed care organizations.
    Williams JP, Lednar W.
    Am J Manag Care; 2002 Apr 11; 8(5 Suppl):S143-54. PubMed ID: 11999801
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of peroral and intranasal immunization of school children with live allantoic influenza vaccine- and comparative study.
    Koval TA, Aleksandrova GI, Grunis AM, Ivannikov YuG, Medvedeva TE, Sychev SV, Shaposhnikova RP, Smorodintsev AA.
    J Hyg Epidemiol Microbiol Immunol; 1979 Apr 11; 23(2):194-200. PubMed ID: 395255
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.
    Coelingh K, Olajide IR, MacDonald P, Yogev R.
    Expert Rev Vaccines; 2015 Apr 11; 14(10):1331-46. PubMed ID: 26372891
    [Abstract] [Full Text] [Related]

  • 18. Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds.
    Rudenko LG, Lonskaya NI, Klimov AI, Vasilieva RI, Ramirez A.
    Bull World Health Organ; 1996 Apr 11; 74(1):77-84. PubMed ID: 8653819
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
    Halloran ME, Piedra PA, Longini IM, Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP.
    Vaccine; 2007 May 16; 25(20):4038-45. PubMed ID: 17395338
    [Abstract] [Full Text] [Related]

  • 20. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.
    Prescrire Int; 2013 Sep 16; 22(141):201-4. PubMed ID: 24171209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.